Applicability of the Platelia EIA® Aspergillus test for the diagnosis of aspergilosis in penguins

• Published in: Brazilian journal of biology Vol. 79; no. 2; pp. 169 - 173
• Main Authors: Cabana, A L, Xavier, M O, Mendes, J F, Teles, A J, Martins, A M, Silva-Filho, R P, Meireles, M C A
• Format: Journal Article
• Language: English
• Published: Brazil Instituto Internacional de Ecologia 01.04.2019
• Subjects: Animals; Antibodies; Antigens; Aspergillosis; Aspergillosis - diagnosis; Aspergillosis - veterinary; Aspergillus; Aspergillus - isolation & purification; Aspergillus fumigatus; BIOLOGY; Biomarkers; Biomarkers - analysis; Birds; Captivity; Diagnosis; Diagnostic systems; Enzyme-linked immunosorbent assay; Enzyme-Linked Immunosorbent Assay - methods; Enzymes; Fungal infections; galactomannan; Immunodiffusion; immunoenzimatic test; Immunoglobulins; Infectious diseases; Mannans - analysis; mycosis; Neutropenia; Reproduction (copying); Sensitivity; Sensitivity analysis; Spheniscidae - microbiology; Statistical tests; Veterinary medicine; United States > US; teste imunoenzimático; micoses; galactomannan; birds; galactomanana; mycosis; aves; immunoenzimatic test
• ISSN: 1519-6984; 1678-4375; 1678-4375
• DOI: 10.1590/1519-6984.171140

Even today, an effective diagnostic test for aspergillosis in penguins is unknown, being the gold standard post-mortem examinations. The fungal antigen galactomannan (GM) has been used as a biomarker of disease in humans and is detected by the Platelia Aspergillus EIA (BioRad)®, a commercial kit based on the sandwich ELISA technique. It is standardized for use in neutropenic patients, however studies have demonstrated its usefulness also possible for birds. The aim of our study was to evaluate the effectiveness of Platelia Aspergillus EIA® test (BioRad-US) in the diagnosis of aspergillosis in Magellanic penguins, determining sensitivity, specificity, and positive and negative predictive values for different cut-off points. Were included in the study, blood serum samples (n = 29) Magellanic penguins in captivity that died by aspergillosis. Detection of GM was performed following manufacturer's instructions and the GM index was obtained by dividing the average value of OD of the duplicate of the clinical sample by duplicate OD of the average value of the cut-off sample provided by the kit. Through information database results were obtained for the presence of anti-Aspergillus fumigatus antibodies detected by agar gel immunodiffusion (AGID) for all serum samples. Results were analyzed using chi-square test and Kruskal-Wallis from SPSS 20.0, IBM®. ROC curve was obtained and from this, rates of sensitivity, specificity, positive and negative predictive values were also calculated based on four different cutoff points (0.5, 1.0, 1.5 and 2.0). The serum GM index did not differ between animals of the case and control group (pkw =0.097). In determining the ROC curve for serum GM detection the value of area under the curve was 0.635. From the values ​​determined by the coordinate of the curve, four different cut points (0.5, 1.0, 1.5 and 2.0) were analyzed, resulting in sensitivity rates ranging from 86.2 to 34.5% % and specificity between 87% and 26.1%. By comparing the serum GM index in group case as the presence or absence of antibodies detected by AGID was found p=0.503. The detection of GM the Platelia Aspergillus EIA® test seems is not be useful for the diagnosis of aspergillosis in naturally infected penguins.